| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.002 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.19 | 0.003 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |